Speaker Profile

Senior Vice President of Global Market Access & Policy, Genapsys Inc

Biography
Cynthia Pointer is the Senior Vice President of Global Market Access & Policy at Genapsys Inc. In this role, she is responsible for market access strategy development, product adoption, and execution of global market advocacy for Genapsys. Cynthia brings over 25 years of immense commercial experience to Genapsys. Her expertise includes global reimbursement, health policy, government affairs, and CMS account management. Cynthia is a recognized leader in managing multinational cross-functional teams and resources to implement strategic reimbursement initiatives specializing in the therapeutic areas of oncology, transplant, age-related macular degeneration, human genetic therapies, pain, and molecular diagnostics. Cynthia has served in major leadership positions in both the pharmaceutical and diagnostic space. Prior to joining Genapsys, Cynthia was the Senior Vice President of Global Market Access at ArcherDX (acquired by Invitae in 2020), a global leader in comprehensive cancer genetics and precision oncology. She has also held various leadership positions at Recro Pharma, Genzyme, Regeneron Pharmaceuticals, and Millennium Pharmaceuticals. Cynthia is uniquely qualified to achieve Genapsys’ mission of transforming research and diagnostics with an affordable, scalable genomic sequencing ecosystem. Cynthia holds a Master of Arts degree specializing in clinical psychology from Marymount University. Cynthia was also voted as one of the top 25 most influential women in biotech during 2020.


 Session Abstract – PMWC 2022 Silicon Valley


  • Dismantling Barriers to Biomarker Testing Through Collaboration (PANEL)
    Session Chair: Omar Perez, AstraZeneca - Nikki Martin, LUNGevity
    - Jenn Higgins, Guardant Health
    - Kamala Maddali, Deep Lens
    - Dan Rhodes, Strata Oncology
  • Health Systems Perspective: Leveraging Real-world Evidence to Improve Patient Care (PANEL)
    Session Chair: Anna Berry, Syapse
    - Mary Walters, Aurora Health
    - Haythem Y Ali, Henry Ford Health System
  • Comprehensive Profiling: Combination of Tissue and Plasma Biomarker Strategies
    Session Chair: Maggie Rougier-Chapman, Personal Genome Diagnostics (PGDx)
    - Cynthia Pointer, Genapsys
    - Ravi Kolhe, Augusta University
    - Stephen Miller, Blueprint Medicines
  • Immuno-oncology Biomarkers for Predicting Drug Efficacy
    Session Chair: Padma Sundar, Oncocyte
    - Paul Billings, Natera
    - Daniel Rhodes, Strata Oncology
  • Reimagining Oncology - Closing the Gaps between Science and Clinic (PANEL)
    Session Chair: Christian Wolfrum, Siemens Healthineers
    - Ben Gonzales, Biognosys AG
    - Debanti Sengupta, Varian
    - Rangarajan Sampath, Siemens Healthineers
    - Steven Artandi, Stanford
  • Challenges to Implementing Precision Oncology in the Community Setting (PANEL)
    Session Chair: Jerry Mitchell, Foundation Medicine
    - Erika Brown, One Cancer Place
    - Lee Schwartzberg, OneOncology
    - Vivian Lee, Patient Advocate
  • Community Hospitals Reimbursement Landscape and Modeling (PANEL)
    Session Chair: Brady Davis, Canexia Health
    - Julie Eggington, CGI (Center for Genomic Interpretation)
    - Jennifer Strickland-Reddy, Sutter Health